Neuromodulation system

The present invention provides a neuromodulation system (100), comprising at least one implant unit (10) and at least one tissue interface module (12), wherein the at least one tissue interface module (12) comprises a lead (14) comprising at least one electrode array with at least one electrode (16, 18, 20, 22) and an electrode circuit (24), wherein system (100) comprises a connection module (26) configured and arranged to form a generic tissue interface module (12) - implant unit (10) interface, and wherein the at least one tissue interface module (12), at least in part, is configured and arranged to define the functionality of the system (100).

The abstract as published by the patent office, from EP4780532A1. It describes the invention; it is not a statement of what is protected.

• Interface and electrodes

  Electrodes and arrays · Peripheral interfaces

• Implant electronics

  Implant electronics

• Packaging

  Packaging and hermeticity

• Stimulation

  Stimulation

What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61B5/24, A61B5/4836, A61N1/0534, A61N1/0551, A61N1/36125). The claims define what a patent protects, and they are not read here.

Interface and electrodes

Everything downstream works with what the contacts pick up. Their number, size and distance from the neurons set the ceiling on the signal. The problem behind it: more contacts, closer to neurons, that still record after years in tissue that reacts to them.

Implant electronics

An implant has room for very little, so functions that fill a rack in the laboratory have to fit on a chip. The problem behind it: fitting channel count, computing and safety functions into a volume and a heat budget the body accepts.

Packaging

Body fluid destroys unprotected electronics. An implant meant to last has to stay sealed for years while passing every channel through its wall. The problem behind it: a seal that lasts as long as the patient needs it, at a size that leaves room for the channels.

Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack

One invention, published 4 times in 4 offices. Each publication opens in Espacenet.

• International (PCT)a route to several countries, not a countryWO2025061735A127 Mar 2025
• ChinaCN122270321A23 Jun 2026
• European Patent Officea route to several countries, not a countryEP4780532A129 Jul 2026
• JapanJP2026532483A29 Sep 2026

1. 18 Sep 2023First filingEarliest priority, at European Patent Office. The family is counted in this year.
2. 18 Sep 2024ApplicationsFiled at International (PCT), China, European Patent Office, Japan.
3. 27 Mar 2025First publicationWO2025061735A1, International (PCT).

Dates as the offices published them. Records of lapses, withdrawals and changes of owner have not been read for this family, and whether a patent is in force today is not assessed.

Organisation

INBRAIN Neuroelectronics · 12 families identified

Use case

Neuromodulation

• Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
• The record itself, with its claims and description: EP4780532A1 in Espacenet
• Counted as a BCI patent family: classified A61N1/0534 (electrodes for deep brain stimulation); filed by INBRAIN NEUROELECTRONICS SL, an organisation already in the graph; describes neural hardware or methods without naming the field; cites a family already accepted. How families are found and judged